chitosan has been researched along with cyclosporine in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (24.00) | 29.6817 |
| 2010's | 15 (60.00) | 24.3611 |
| 2020's | 4 (16.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso, MJ; De Campos, AM; Sánchez, A | 1 |
| Alonso, MJ; Sánchez, A | 1 |
| Italia, JL; Ravi Kumar, MN; Sharma, G; Sonaje, K; Tikoo, K | 1 |
| Alonso, MJ; de la Fuente, M; Seijo, B | 1 |
| Jaafari, MR; Malaekeh-Nikouei, B; Sajadi Tabassi, SA | 1 |
| Auriola, S; Holappa, J; Jarho, P; Järvinen, K; Mannila, J; Matilainen, L | 1 |
| Beskonakli, E; Bodur, E; Eroglu, H; Gurcan, O; Oner, L; Sargon, MF; Turkoglu, OF | 1 |
| Bonferoni, MC; Caramella, C; Ferrari, F; Gökçe, EH; Patrini, M; Rossi, S; Sandri, G | 1 |
| Gellert, P; Le, H; Schatzlein, A; Siew, A; Thiovolet, M; Uchegbu, I | 1 |
| Everaert, A; Hermans, K; Ludwig, A; Van den Plas, D; Weyenberg, W | 1 |
| Liu, JH; Wei, XH; Zhang, L; Zhao, ZL | 1 |
| Chen, D; Gan, Y; Li, X; Xia, D; Yu, H; Zhu, C; Zhu, Q | 1 |
| Başaran, E; Berkman, MS; Büyükköroğlu, G; Yazan, Y; Yenilmez, E | 1 |
| Ding, F; Jiang, G; Sun, J | 1 |
| Amini, K; Heydarian, H; Mohammadi, R | 1 |
| Adriaensens, P; Carleer, R; Hermans, K; Kerimova, S; Ludwig, A; Van den Plas, D; Weyenberg, W | 1 |
| Deng, J; Liu, C; Lv, H; Yin, L; Zhang, Z; Zhou, J | 1 |
| Chen, C; Chen, YP; Gu, HY; Guo, LY; He, H; Li, XD; Shen, LL; Wang, YF; Xia, DL | 1 |
| Bonferoni, MC; Caramella, C; Dellera, E; Ferrari, F; Rossi, S; Sandri, G; Zambito, Y | 1 |
| Liu, M; Yang, Z; Zhong, X | 1 |
| Ding, DJ; Gao, YY; Li, WT; Liu, K; Qin, M; Wen, BF; Yang, TT; Zhang, WF; Zhang, YX | 1 |
| Cassano, R; Curcio, F; Pellegrino, M; Poerio, T; Russo, R; Trombino, S | 1 |
| Chen, S; Ji, X; Jin, J; Zhang, H; Zhao, L; Zhao, M | 1 |
| Chen, Y; Fang, P; Hao, S; He, H; Hu, H; Li, Y; Xiong, M; Xu, M; Yu, S | 1 |
| Abduh, MS | 1 |
1 review(s) available for chitosan and cyclosporine
| Article | Year |
|---|---|
The potential of chitosan in ocular drug delivery.
Topics: Administration, Topical; Biocompatible Materials; Chitin; Chitosan; Cyclosporine; Drug Delivery Systems; Eye; Humans | 2003 |
24 other study(ies) available for chitosan and cyclosporine
| Article | Year |
|---|---|
Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
Topics: Administration, Topical; Animals; Antifungal Agents; Chitin; Chitosan; Conjunctiva; Cornea; Cyclosporine; Drug Carriers; Drug Delivery Systems; Eye; Male; Microscopy, Electron; Mucous Membrane; Ophthalmic Solutions; Particle Size; Rabbits | 2001 |
Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
Topics: Animals; Antioxidants; Biological Availability; Chitosan; Cyclosporine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ellagic Acid; Ethanolamines; Gels; Glycerol; Immunosuppressive Agents; Kidney; Kinetics; Lactic Acid; Male; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Propylene Glycol; Rats; Rats, Sprague-Dawley; Solvents; Temperature; Water | 2007 |
Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules.
Topics: Chitosan; Cyclosporine; Drug Carriers; Drug Delivery Systems; Hyaluronic Acid; Macromolecular Substances; Materials Testing; Nanoparticles; Serum Albumin, Bovine | 2008 |
Preparation, characterization, and mucoadhesive properties of chitosan-coated microspheres encapsulated with cyclosporine A.
Topics: Adhesiveness; Cell Proliferation; Chemistry, Pharmaceutical; Chitosan; Chromatography, High Pressure Liquid; Cyclosporine; Drug Carriers; Drug Compounding; Humans; Immunosuppressive Agents; In Vitro Techniques; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Mucins; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Surface Properties; T-Lymphocytes | 2008 |
Cyclodextrins and chitosan derivatives in sublingual delivery of low solubility peptides: A study using cyclosporin A, alpha-cyclodextrin and quaternary chitosan N-betainate.
Topics: Administration, Sublingual; Algorithms; alpha-Cyclodextrins; Animals; Area Under Curve; Betaine; Biological Availability; Chitosan; Chromatography, High Pressure Liquid; Cold Temperature; Cyclodextrins; Cyclosporine; Drug Delivery Systems; Drug Stability; Half-Life; Male; Peptides; Rabbits; Solubility; Spectrometry, Mass, Electrospray Ionization | 2009 |
Local administration of chitosan microspheres after traumatic brain injury in rats: a new challenge for cyclosporine--a delivery.
Topics: Animals; Brain Injuries; Chitosan; Cyclosporine; Disease Models, Animal; Male; Microspheres; Mitochondria; Rats; Rats, Sprague-Dawley | 2010 |
Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems.
Topics: Animals; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Cornea; Cyclosporine; Drug Compounding; Drug Stability; Electrochemistry; Excipients; Freeze Drying; Immunosuppressive Agents; In Vitro Techniques; Indicators and Reagents; Liposomes; Microscopy, Atomic Force; Microscopy, Confocal; Nanoparticles; Ophthalmic Solutions; Particle Size; Poloxamer; Polysorbates; Skin Absorption; Surface-Active Agents; Swine; Ultrasonics | 2010 |
Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles.
Topics: Adhesiveness; Animals; Anti-Ulcer Agents; Antibiotics, Antineoplastic; Antifungal Agents; Caco-2 Cells; Chitosan; Cyclosporine; Drug Carriers; Griseofulvin; Humans; Hydrophobic and Hydrophilic Interactions; Idarubicin; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Male; Nanoparticles; Quaternary Ammonium Compounds; Ranitidine; Rats; Rats, Wistar | 2012 |
Full factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticles.
Topics: Animals; Cations; Chitosan; Cyclosporine; Drug Carriers; Drug Compounding; Emulsions; Epithelial Cells; Humans; Immunosuppressive Agents; Jurkat Cells; Lactic Acid; Mucus; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solvents; Static Electricity; Swine; Tears | 2012 |
Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles.
Topics: Animals; Area Under Curve; Biological Availability; Chitosan; Cyclosporine; Nanoparticles; Polyethylene Glycols; Rabbits | 2013 |
Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
Topics: Adhesiveness; Administration, Oral; Animals; Area Under Curve; Chitosan; Cyclosporine; Drug Carriers; Drug Delivery Systems; Fluorophotometry; Immunosuppressive Agents; Intestinal Absorption; Intestinal Mucosa; Liposomes; Male; Microscopy, Confocal; Poloxamer; Rats; Rats, Sprague-Dawley; Solubility | 2013 |
Chitosan nanoparticles for ocular delivery of cyclosporine A.
Topics: Animals; Chitosan; Cyclosporine; Delayed-Action Preparations; Eye; Immunosuppressive Agents; Nanoparticles; Sheep | 2014 |
PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: cytotoxicity, in vivo degradation and drug release.
Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Chitosan; Cyclosporine; Drug Carriers; Drug Implants; Hydrogel, Polyethylene Glycol Dimethacrylate; Male; Mice; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Temperature | 2014 |
Effect of local administration of cyclosporine A on peripheral nerve regeneration in a rat sciatic nerve transection model.
Topics: Animals; Chitosan; Cyclosporine; Immunohistochemistry; Nerve Regeneration; Rats; Sciatic Nerve | 2014 |
Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adhesiveness; Administration, Ophthalmic; beta-Cyclodextrins; Cell Line; Cell Survival; Chitosan; Cyclosporine; Drug Delivery Systems; Excipients; Glycerol; Humans; Interleukin-2; Mucous Membrane; Plasticizers; Water | 2014 |
The studies of N-Octyl-N-Arginine-Chitosan coated liposome as an oral delivery system of Cyclosporine A.
Topics: Administration, Oral; Animals; Arginine; Chitosan; Cyclosporine; Drug Carriers; Drug Delivery Systems; Drug Liberation; Emulsions; Gastrointestinal Tract; Immunosuppressive Agents; Liposomes; Male; Particle Size; Rats; Rats, Sprague-Dawley | 2015 |
Effect of "phase change" complex on postoperative adhesion prevention.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Calcium Chloride; Chitosan; Cyclosporine; Drug Combinations; Female; Immunosuppressive Agents; Intestines; Male; Peritoneal Diseases; Postoperative Complications; Rats; Rats, Sprague-Dawley; Single-Blind Method; Tissue Adhesions; Treatment Outcome | 2016 |
Palmitoyl Glycol Chitosan Micelles for Corneal Delivery of Cyclosporine.
Topics: Animals; Chitosan; Cornea; Cyclosporine; Diffusion; Immunosuppressive Agents; Injections, Intraocular; Micelles; Nanocapsules; Swine | 2016 |
Chitosan functionalized nanocochleates for enhanced oral absorption of cyclosporine A.
Topics: Actins; Administration, Oral; Biological Transport; Caco-2 Cells; Chitosan; Claudin-4; Cyclosporine; Disaccharides; Drug Liberation; Humans; Microscopy, Fluorescence; Nanoparticles; Particle Size; Tissue Distribution; Zonula Occludens-1 Protein | 2017 |
Cyclosporine A/porous quaternized chitosan microspheres as a novel pulmonary drug delivery system.
Topics: Animals; Cell Differentiation; Chitosan; Cyclosporine; Drug Carriers; Female; Interleukin-4; L-Lactate Dehydrogenase; Leukocytes; Lung; Male; Materials Testing; Microspheres; Particle Size; Porosity; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2018 |
Chitosan Membranes Filled with Cyclosporine A as Possible Devices for Local Administration of Drugs in the Treatment of Breast Cancer.
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Cyclosporine; Drug Carriers; Humans; Membranes; Swine | 2021 |
Construction of chitooligosaccharide-based nanoparticles of pH/redox cascade responsive for co-loading cyclosporin A and AZD9291.
Topics: Acrylamides; Aniline Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chitosan; Cyclosporine; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Indoles; Lung Neoplasms; Nanoparticles; Oligosaccharides; Oxidation-Reduction; Pyrimidines; Tumor Microenvironment | 2022 |
Cyclosporine A-loaded colon-targeted oral nanomicelles self-assembly by galactosylated carboxymethyl chitosan for efficient ulcerative colitis therapy.
Topics: Animals; Chitosan; Colitis, Ulcerative; Cyclosporine; Dextran Sulfate; Mice; Nanoparticles; Polymers | 2023 |
Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer.
Topics: Cell Line, Tumor; Chitosan; Cyclosporine; Delayed-Action Preparations; Drug Carriers; Humans; Hyaluronan Receptors; Hyaluronic Acid; Nanoparticles; Triple Negative Breast Neoplasms | 2023 |